Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Filaggrin Gene Polymorphisms in Iranian Ichthyosis Vulgaris and Atopic Dermatitis Patients Publisher Pubmed



Hassani B1 ; Isaian A2 ; Shariat M3 ; Mollanoori H1 ; Sotoudeh S4 ; Babaei V1 ; Ziaali A5 ; Teimourian S1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Genetics, Iran University of Medical Sciences (IUMS), Tehran, Iran
  2. 2. Department of Pathology, Tehran University of Medical Sciences (TUMS), Tehran, Iran
  3. 3. Department of Immunology and Allergy, Children's Medical Center, Tehran University of Medical Sciences (TUMS), Tehran, Iran
  4. 4. Department of Dermathology, Children's Medical Center, Tehran University of Medical Sciences (TUMS), Tehran, Iran
  5. 5. Children's Medical Center, Tehran University of Medical Sciences (TUMS), Tehran, Iran

Source: International Journal of Dermatology Published:2018


Abstract

Background: Filaggrin is a key structural epidermal protein in terminal differentiation and formation of skin barrier. The important role of filaggrin and its effects in various cutaneous and noncutaneous disorders initiated a cascade of considerable research in recent years. Loss-of-function mutations in FLG, the human gene encoding profilaggrin/filaggrin, is the cause of the common skin condition ichthyosis vulgaris (IV) and major genetic predisposing factor for atopic dermatitis (AD). Several null mutations in the FLG gene that lead to a decrease or absence of filaggrin in skin and predispose these conditions have been described. Objective: The aim of this study was to investigative genetic polymorphism of FLG in Iranian patients with IV and AD. Methods: In the current study, we carried out full sequencing of the entire FLG coding region in 30 IV patients and 30 AD patients, and also 60 healthy controls. Results: In our research, we identified 43 variants reported previously and two novel variants. Conclusion: In our study, in the AD and IV patients, loss-of-function FLG mutation was not found. This means that another mechanism other than FLG nonsense mutation is involved in the pathogenesis of these patients. © 2018 The International Society of Dermatology
Related Docs
Experts (# of related papers)